tradingkey.logo

Nano-X Imaging Ltd

NNOX
2.440USD
+0.160+7.02%
Close 02/06, 16:00ETQuotes delayed by 15 min
159.53MMarket Cap
LossP/E TTM

Nano-X Imaging Ltd

2.440
+0.160+7.02%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Nano-X Imaging Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Nano-X Imaging Ltd's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 109 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.40.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nano-X Imaging Ltd's Score

Industry at a Glance

Industry Ranking
109 / 205
Overall Ranking
286 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Nano-X Imaging Ltd Highlights

StrengthsRisks
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 31.53% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.28M.
Overvalued
The company’s latest PE is -2.76, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 13.93M shares, decreasing 32.91% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 6.04K shares of this stock.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
7.400
Target Price
+224.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Nano-X Imaging Ltd is 6.15, ranking 169 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 3.45M, representing a year-over-year increase of 13.72%, while its net profit experienced a year-over-year increase of 0.33%.

Score

Industry at a Glance

Previous score
6.15
Change
0

Financials

9.15

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.27

Operational Efficiency

2.83

Growth Potential

4.44

Shareholder Returns

7.07

Nano-X Imaging Ltd's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Nano-X Imaging Ltd is 7.53, ranking 77 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.76, which is -6.56% below the recent high of -2.58 and -335.36% above the recent low of -12.01.

Score

Industry at a Glance

Previous score
7.53
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 109/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Nano-X Imaging Ltd is 8.50, ranking 24 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 7.50, with a high of 10.60 and a low of 7.00.

Score

Industry at a Glance

Previous score
8.50
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
7.400
Target Price
+224.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Nano-X Imaging Ltd
NNOX
4
Boston Scientific Corp
BSX
36
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Nano-X Imaging Ltd is 5.15, ranking 184 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.09 and the support level at 2.03, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
4.95
Change
0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.127
Sell
RSI(14)
35.733
Neutral
STOCH(KDJ)(9,3,3)
11.672
Oversold
ATR(14)
0.237
Low Volatility
CCI(14)
-119.150
Sell
Williams %R
83.491
Oversold
TRIX(12,20)
-0.635
Sell
StochRSI(14)
70.420
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.482
Sell
MA10
2.718
Sell
MA20
2.893
Sell
MA50
3.172
Sell
MA100
3.456
Sell
MA200
4.170
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Nano-X Imaging Ltd is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 20.13%, representing a quarter-over-quarter decrease of 3.59%. The largest institutional shareholder is The Vanguard, holding a total of 400.45K shares, representing 0.58% of shares outstanding, with 1.15% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
3.13M
-1.57%
UBS Switzerland AG
951.57K
+88.24%
State Street Investment Management (US)
1.16M
-1.05%
Geode Capital Management, L.L.C.
787.16K
-2.86%
UBS Asset Management Switzerland AG
650.00K
--
Susquehanna International Group, LLP
429.20K
+191.10%
The Vanguard Group, Inc.
Star Investors
390.33K
-5.45%
ARK Investment Management LLC
Star Investors
384.79K
+22.12%
Morgan Stanley Smith Barney LLC
343.10K
-7.11%
Northern Trust Investments, Inc.
337.36K
-3.22%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Nano-X Imaging Ltd is 3.66, ranking 119 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.38. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Nano-X Imaging Ltd’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Score

Industry at a Glance

Previous score
3.66
Change
0
Beta vs S&P 500 index
1.38
VaR
+7.52%
240-Day Maximum Drawdown
+64.38%
240-Day Volatility
+70.50%

Return

Best Daily Return
60 days
+26.38%
120 days
+26.38%
5 years
+68.41%
Worst Daily Return
60 days
-10.60%
120 days
-10.60%
5 years
-20.15%
Sharpe Ratio
60 days
-0.51
120 days
-1.24
5 years
-0.21

Risk Assessment

Maximum Drawdown
240 days
+64.38%
3 years
+89.40%
5 years
+93.58%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.21
5 years
-0.20
Skewness
240 days
+1.50
3 years
+3.70
5 years
+2.84

Volatility

Realised Volatility
240 days
+70.50%
5 years
+89.65%
Standardised True Range
240 days
+10.78%
5 years
+31.87%
Downside Risk-Adjusted Return
120 days
-271.57%
240 days
-271.57%
Maximum Daily Upside Volatility
60 days
+98.18%
Maximum Daily Downside Volatility
60 days
+58.99%

Liquidity

Average Turnover Rate
60 days
+1.87%
120 days
+1.85%
5 years
--
Turnover Deviation
20 days
-30.52%
60 days
-37.48%
120 days
-38.27%

Peer Comparison

Healthcare Equipment & Supplies
Nano-X Imaging Ltd
Nano-X Imaging Ltd
NNOX
6.06 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI